Cyclometalated ruthenium (II) complexes induced HeLa cell apoptosis through intracellular reductive injury

[1]  L. Ji,et al.  Ruthenium(II) complexes coordinated to graphitic carbon nitride: Oxygen self-sufficient photosensitizers which produce multiple ROS for photodynamic therapy in hypoxia. , 2021, Biomaterials.

[2]  Lintao Cai,et al.  Enhancing the ROS generation ability of a rhodamine-decorated iridium(iii) complex by ligand regulation for endoplasmic reticulum-targeted photodynamic therapy† , 2020, Chemical science.

[3]  I. Batinic-Haberle,et al.  The SOD Mimic MnTnHex-2-PyP5+ Reduces the Viability and Migration of 786-O Human Renal Cancer Cells , 2019, Antioxidants.

[4]  G. Krasnov,et al.  ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells , 2019, Oxidative medicine and cellular longevity.

[5]  Sanjeev Kumar,et al.  Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD) , 2018, Cellular Oncology.

[6]  G. Chiosis,et al.  Adapting to stress — chaperome networks in cancer , 2018, Nature Reviews Cancer.

[7]  Lanmei Chen,et al.  Cytotoxicity in vitro, cellular uptake, localization and apoptotic mechanism studies induced by ruthenium(II) complex , 2018, JBIC Journal of Biological Inorganic Chemistry.

[8]  Lanmei Chen,et al.  Synthesis, characterization, cellular uptake and apoptosis-inducing properties of two highly cytotoxic cyclometalated ruthenium(II) β-carboline complexes. , 2017, European journal of medicinal chemistry.

[9]  P. Mouthuy,et al.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) , 2017, Redox biology.

[10]  Yazhe Wang,et al.  Anti-tumor activity and mechanism of apoptosis of A549 induced by ruthenium complex , 2016, JBIC Journal of Biological Inorganic Chemistry.

[11]  Ya-jun Hou,et al.  DSePA Antagonizes High Glucose-Induced Neurotoxicity: Evidences for DNA Damage-Mediated p53 Phosphorylation and MAPKs and AKT Pathways , 2016, Molecular Neurobiology.

[12]  Cheng Zhang,et al.  Apoptosis, autophagy, cell cycle arrest, cell invasion and BSA-binding studies in vitro of ruthenium(II) polypyridyl complexes , 2016 .

[13]  Lanmei Chen,et al.  The studies on the cytotoxicity in vitro, cellular uptake, cell cycle arrest and apoptosis-inducing properties of ruthenium methylimidazole complex [Ru(MeIm)4(p-cpip)](2.). , 2016, Journal of inorganic biochemistry.

[14]  J. Muller,et al.  A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway. , 2015, Molecular pharmaceutics.

[15]  L. Ji,et al.  Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells. , 2015, Chemistry.

[16]  A. Kamal,et al.  Design and synthesis of dithiocarbamate linked β-carboline derivatives: DNA topoisomerase II inhibition with DNA binding and apoptosis inducing ability. , 2015, Bioorganic & medicinal chemistry.

[17]  Wenqiang Cao,et al.  Rational Design of Ruthenium Complexes Containing 2,6‐Bis(benzimidazolyl)pyridine Derivatives with Radiosensitization Activity by Enhancing p53 Activation , 2015, ChemMedChem.

[18]  Wen-jie Zheng,et al.  Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS. , 2015, European journal of medicinal chemistry.

[19]  L. Ji,et al.  Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex. , 2014, Journal of medicinal chemistry.

[20]  A. Kamal,et al.  Design and Synthesis of C3‐Pyrazole/Chalcone‐Linked Beta‐Carboline Hybrids: Antitopoisomerase I, DNA‐Interactive, and Apoptosis‐Inducing Anticancer Agents , 2014, ChemMedChem.

[21]  Wen-jie Zheng,et al.  Synergistic induction of apoptosis by methylseleninic acid and cisplatin, the role of ROS-ERK/AKT-p53 pathway. , 2014, Molecular pharmaceutics.

[22]  L. Ji,et al.  Synthesis, characterization, and anticancer activity of ruthenium(II)-β-carboline complex. , 2013, European journal of medicinal chemistry.

[23]  L. Ji,et al.  A ruthenium(II) β-carboline complex induced p53-mediated apoptosis in cancer cells. , 2013, Biochimie.

[24]  P. Brambilla,et al.  Differential protein profiling of renal cell carcinoma urinary exosomes. , 2013, Molecular bioSystems.

[25]  D. Šuput,et al.  Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants , 2013, Oxidative medicine and cellular longevity.

[26]  N. Chandel,et al.  Physiological roles of mitochondrial reactive oxygen species. , 2012, Molecular cell.

[27]  G. Barrera.  Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy , 2012, ISRN oncology.

[28]  F. Castellano,et al.  Spectroscopy and Photophysics in Cyclometalated RuII–Bis(bipyridyl) Complexes , 2012 .

[29]  Omer Kalayci,et al.  Oxidative Stress and Antioxidant Defense , 2012, The World Allergy Organization journal.

[30]  Xiao‐Xin Shi,et al.  Efficient and Practical One-Pot Conversions of N-Tosyltetrahydroisoquinolines into Isoquinolines and of N-Tosyltetrahydro-β-carbolines into β-Carbolines through Tandem β-Elimination and Aromatization , 2010 .

[31]  A. Xu,et al.  Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis. , 2010, Journal of medicinal chemistry.

[32]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[33]  Wen-jie Zheng,et al.  Caspase- and p53-dependent apoptosis in breast carcinoma cells induced by a synthetic selenadiazole derivative. , 2009, Chemico-biological interactions.

[34]  Jinshui Fan,et al.  Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. , 2008, Cancer letters.

[35]  Y. Wong,et al.  Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation , 2008, Cellular and Molecular Life Sciences.

[36]  Tianfeng Chen,et al.  In vitro antioxidant and antiproliferative activities of selenium-containing phycocyanin from selenium-enriched Spirulina platensis. , 2008, Journal of agricultural and food chemistry.

[37]  Wen-jie Zheng,et al.  Mitochondria-mediated apoptosis in human breast carcinoma MCF-7 cells induced by a novel selenadiazole derivative. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[38]  Anlong Xu,et al.  β-Carboline Alkaloids: Biochemical and Pharmacological Functions , 2007 .

[39]  W. Dröge.  Oxidative aging and insulin receptor signaling. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[40]  N. Oliveira,et al.  Redox Therapeutics in Breast Cancer: Role of SOD Mimics , 2016 .